TGFB2 was included in a four gene signature (FN1, TGFB2, TGFBR2, and TGFBI), as an indicator of CAF abundance, which predicted survival in TCGA pan-cancer cohort comprising 9356 patients from 32 cancer subtypes [59]. The gene discussed is TGFBR2; the disease is cancer.